TNF and rheumatoid arthritis: We found the maximum tolerated dose of seliciclib, an orally available CDK inhibitor, in a phase 1b trial among patients with rheumatoid arthritis refractory to TNF blockade, further evaluating the safety and tolerability of the intervention.